Agios Pharmaceuticals Inc

NASDAQ:AGIO   4:00:00 PM EDT
33.26
-0.21 (-0.63%)
4:32:49 PM EDT: $33.26 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.93B
Current PE2.89
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$9.54 Million
Adjusted EPS-$1.81
See more estimates
10-Day MA$33.58
50-Day MA$31.29
200-Day MA$37.38
See more pivots

Agios Pharmaceuticals Inc Stock, NASDAQ:AGIO

88 Sidney Street, 88 Sidney Street, Cambridge, Massachusetts 02139-4169
United States of America
Phone: +1.617.649.8600
Number of Employees: 488

Description

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.